We would like to use Illumina's TruSeq kit to prepare libraries for paired end RNA-seq. I would like to shoot for a longer insert size and am considering trying fragmentation with the Covaris method or a nebulizer. Any suggestions, advice, protocols, guidance, links would be greatly appreciated. Also - what size do you aim for?
-
-
We tried all different conditions that they recommended for longer sizes and none worked well.
I would suggest creating full length cDNA from your RNA using other methods than the kit (SSIII for example) and then use a covaris to shear to the length you want. We have customers that do this very well. -
Hi Kwaraska,
Can you give me more information about the protocol used by your customers?
Can you describe the steps until you get cDNA from your non-fragmented RNA?Comment
-
For cDNA conversion we use the Invitrogen products SSIII and second strand kit. We just follow the protocols.
Then we follow the Covaris recommended protocols for the different sizes. There is a sheet on their website that gives you conditions for all different sizes. On cDNA they work well and true to size.Comment
-
Thank you very much kwaraska for your answer. We are also interested in preparing paired end Truseq stranded RNA seq with 200-300 bp inserts . In its protocol Illumina used dUTP for cDNA conversion and inserts are shorter than 200bp. Could someone give me advice how to proceed?Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment